![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
DSM, DecImmune collaborate to develop N2 pathway blocking antibody
DSM Pharmaceutical Products has entered into collaboration with venture capital funded DecImmune Therapeutics of...
Sunshine looking for CMOs for breast cancer drug Adva-27a manufacturing
Sunshine Biopharma has started discussions with contract manufacturing organizations (CMOs) for the production of...
Qualicaps to invest $26m for Whitsett facility expansion
Pharmaceutical manufacturer Qualicaps will invest $26m to expand its facility in Whitsett, North Carolina...
Bone Therapeutics to build new manufacturing facility in Belgium
Biopharmaceutical company Bone Therapeutics has announced that it has made a €10m investment in...
PCT to provide development, manufacturing services to Adaptimmune
Progenitor Cell Therapy (PCT), a subsidiary of NeoStem, has signed an agreement to provide...
Amgen to invest $200m in new Singapore manufacturing facility
Amgen is planning to invest $200m to construct a manufacturing facility in the Tuas...
Impax, Perrigo to jointly develop topical generic drug
Impax Laboratories and Perrigo Company have signed a deal to develop and manufacture an...
Fujifilm to manufacture bulk substance for ThromboGenics’ eye medication
Fujifilm Diosynth Biotechnologies will manufacture the bulk substance for ThromboGenics' FDA approved Jetrea (ocriplasmin)...
Mylan Labs to buy SMS Indian manufacturing unit
Mylan Laboratories has agreed to purchase SMS Pharmaceuticals' manufacturing unit-VI in Visakhapatnam, Andhra Pradesh,...
Biostar to manufacture, supply five additional drugs to Xijing Hospital
Biostar Pharmaceuticals has entered into an agreement worth $3m to manufacture and supply five...